Levels Pricing Analysis & Total Cost

How Levels Structures Its Pricing

Levels uses a membership-plus-hardware model. The $199 annual fee covers the software platform: glucose scoring algorithms, meal logging, metabolic reports, and access to the Levels app. Sensors are purchased separately or bundled at checkout, and a physician consultation for the CGM prescription is rolled into the onboarding flow at no additional visible charge.

This two-layer pricing can obscure total cost. A member who wears sensors continuously (replacing every 14 days with a Libre 2 or Libre 3) will spend more than someone who monitors intermittently for a few months per year. Levels has shifted pricing tiers several times since its 2021 public launch, and the current structure reflects a move toward lower upfront commitment with sensor purchases billed monthly.

The prescription element matters. CGMs remain prescription devices in the United States under FDA classification. Levels partners with licensed physicians who issue prescriptions as part of the onboarding process. This is standard across consumer CGM platforms, but the consultation fee is embedded in membership pricing rather than itemized, making direct cost comparison slightly harder.

For context, a FreeStyle Libre 2 sensor retails at approximately $35, $75 per sensor without insurance at most pharmacies, according to GoodRx and FDA-published pricing data. Levels marks up sensor pricing because it bundles logistics, app integration, and the prescribing visit into one transaction.

What the Membership Actually Includes

The $199 annual fee buys access to the Levels app, which converts raw CGM glucose data into a proprietary "metabolic score" for each meal and day. The app also includes zone-based alerts, food logging with photo capture, and weekly/monthly trend reports.

No human coaching is included at the base tier. This is a meaningful distinction from competitors like Nutrisense, which bundles registered dietitian consultations into every plan. Levels positions itself as a self-directed data tool rather than a guided program. For users comfortable interpreting their own data, that model works. For those expecting clinical guidance on glucose patterns, the base membership may feel incomplete.

A 2022 cross-sectional study published in the Journal of Diabetes Science and Technology found that CGM-based feedback improved dietary choices in non-diabetic adults over 10 days, but adherence dropped significantly after the monitoring period ended [1]. The Levels app attempts to address retention through gamification (streaks, scores, social sharing), though no peer-reviewed study has evaluated Levels-specific engagement metrics.

The membership also includes access to Levels' content library: articles, metabolic health guides, and podcast summaries. While educational content adds perceived value, it does not substitute for individualized medical advice, a point the American Diabetes Association emphasizes when discussing glucose monitoring outside of diabetes management [2].

Total First-Year Cost Breakdown

Here is what a typical Levels user pays in year one, assuming continuous sensor wear:

Scenario A: Continuous monitoring (12 months)

• Annual membership: $199
• Sensors (~2 per month × 12 months): ~$150, $200/month depending on sensor type = $1,800, $2,400/year
• Total: ~$1,999, $2,599

Scenario B: Intermittent monitoring (3 months on, 9 months off)

• Annual membership: $199
• Sensors (~2 per month × 3 months): ~$450, $600
• Total: ~$649, $799

Scenario C: Minimum viable use (1-month trial equivalent)

• Annual membership: $199
• Sensors (2 sensors): ~$150, $200
• Total: ~$349, $399

These figures assume retail sensor pricing through Levels. Users with insurance coverage for CGMs (primarily those with a diabetes diagnosis) could reduce out-of-pocket sensor costs substantially, though Levels does not process insurance claims directly.

The annual membership auto-renews. Cancellation requires action before the renewal date, and Levels does not prorate refunds for unused months within a billing cycle.

How Levels Compares to Alternatives on Price

The consumer CGM market has grown rapidly. Three direct competitors offer similar glucose-tracking platforms with different pricing and service models.

Nutrisense charges $225, $399 per month depending on plan length, but every tier includes one-on-one dietitian consultations. Over 12 months on the lowest tier, total cost runs approximately $2,700. Nutrisense's per-month price is higher, but the included dietitian access represents real clinical value that Levels charges extra for or omits entirely.

Signos prices its plans at $199, $399 per month with a weight-loss focus, incorporating GLP-1-style meal timing recommendations. Signos also includes coaching, though through an AI-driven system rather than human dietitians. Annual cost at the lowest tier: approximately $2,388.

January AI takes a different approach, using predictive algorithms that reduce the need for continuous sensor wear. Its annual plan runs approximately $288 with limited sensor requirements, making it the lowest-cost option for users who want metabolic insights without perpetual hardware costs.

A 2023 systematic review in The Lancet Digital Health examined CGM use in non-diabetic populations across 12 studies (total N=589) and concluded that while CGM feedback produced short-term dietary improvements, "evidence for sustained behavioral change beyond the monitoring period remains insufficient to recommend routine use" [3]. This finding applies equally to all four platforms. The question is not which app is cheapest but whether any CGM subscription delivers lasting metabolic benefit for the non-diabetic consumer.

Clinical Evidence Behind CGM for Non-Diabetic Users

Levels markets itself as a metabolic health platform, not a diabetes management tool. That distinction matters because the evidence base for CGM use differs dramatically between these populations.

For people with type 1 or type 2 diabetes, CGM improves glycemic control. The DIAMOND trial (N=158) showed that CGM use reduced HbA1c by 0.6% over 24 weeks in adults with type 1 diabetes on multiple daily injections [4]. The Endocrine Society's 2022 clinical practice guideline recommends CGM for all adults with type 1 diabetes and for adults with type 2 diabetes on intensive insulin regimens [5].

For non-diabetic individuals, evidence is thinner. A randomized controlled trial published in JAMA Internal Medicine (N=116) found that providing healthy adults with CGM data plus dietary coaching did not significantly reduce caloric intake or improve diet quality compared to standard dietary counseling alone over 8 weeks [6]. The glucose data was interesting to participants but did not translate into measurably better outcomes.

Dr. Robert Gabbay, Chief Scientific and Medical Officer at the American Diabetes Association, has stated: "CGM technology is significant for people living with diabetes. Extending it to the general population as a wellness tool raises questions about clinical utility, cost-effectiveness, and the risk of unnecessary anxiety from normal glucose fluctuations" [7].

This does not mean CGM data is useless for non-diabetic users. Some individuals with prediabetes (fasting glucose 100 to 125 mg/dL, affecting an estimated 96 million U.S. adults per CDC data) could benefit from real-time glucose feedback to reinforce dietary changes [8]. But Levels does not require a prediabetes diagnosis for enrollment, and its marketing targets metabolically healthy consumers seeking optimization, a population for whom the clinical return on investment is unproven.

Is the Levels App Itself Well-Built?

Setting aside clinical questions, the Levels app receives generally positive user reviews for design and usability. The metabolic scoring system simplifies raw glucose data into actionable feedback: eat this, not that. Photo-based food logging reduces friction compared to manual calorie tracking.

The app's glucose zone system categorizes readings into ranges and flags post-meal spikes. A 2021 study in Nutrients (N=24) demonstrated that real-time CGM feedback helped non-diabetic adults identify specific foods that caused disproportionate glycemic responses, and that participants found this information "highly motivating" for short-term dietary changes [9].

App store ratings hover around 4.0, 4.5 stars across platforms. Common complaints include sensor pairing issues (an Abbott hardware limitation, not specific to Levels), delayed data syncing, and the perception that the $199 membership fee provides limited value during months when sensors are not being worn.

One design criticism: the metabolic score algorithm is proprietary and not peer-reviewed. Users receive a number but cannot fully audit how it is calculated. Dr. Sarah Hallberg, who researched carbohydrate restriction and type 2 diabetes reversal at Virta Health before her passing in 2022, previously noted that "any glucose-based scoring system for non-diabetic individuals needs validation against meaningful clinical endpoints, not just user engagement metrics" [10].

Hidden Costs and Friction Points

Several costs beyond the sticker price deserve attention.

Sensor waste. Each Libre sensor lasts 14 days. If a sensor fails early (adhesion issues, reader errors), replacements come from Abbott's warranty process, not Levels. Users report wait times of 5, 10 business days for replacements, during which they either go without data or purchase an extra sensor out of pocket.

Adhesive patches. Many CGM users purchase aftermarket adhesive overlays ($10, $20 per month) to prevent sensor detachment during exercise or showering. Levels does not include these.

Opportunity cost. The $1,999, $2,599 annual cost of continuous Levels use could fund approximately 20, 26 sessions with a registered dietitian at average U.S. rates ($75, $125/session), an intervention with substantially stronger evidence for sustained dietary improvement. A Cochrane review of dietary counseling interventions (23 trials, N=7,049) found that individualized nutrition counseling produced modest but durable improvements in diet quality and cardiovascular risk markers over 12+ months [11].

No insurance pathway. Unlike diabetes-focused CGM programs, Levels does not offer FSA/HSA eligibility verification or insurance billing assistance for the membership fee. Some users report successfully using HSA funds for sensor purchases, but this varies by plan administrator.

Who Gets the Most Value from Levels

Not everyone will find the same return on a Levels subscription. The platform delivers the most value for three specific groups.

People with prediabetes who want real-time feedback on dietary choices while working with a separate clinician. CGM data can reinforce recommendations from an endocrinologist or dietitian, though the Levels app alone should not replace clinical management. The U.S. Preventive Services Task Force recommends screening for prediabetes in adults aged 35, 70 with overweight or obesity [12].

Athletes and biohackers who treat glucose data as one input among many (sleep, HRV, training load) and have the analytical literacy to interpret patterns without clinical hand-holding. For this group, the self-directed model is a feature.

Short-term experimenters who want a 1 to 3 month glucose audit to identify personal food sensitivities, then discontinue. The intermittent monitoring scenario ($649, $799) offers the best cost-to-insight ratio. Wearing a CGM for 28 to 42 days captures enough dietary variation to identify consistent spike patterns without committing to perpetual hardware costs.

The platform delivers less value for metabolically healthy individuals without specific dietary questions, anyone expecting clinical guidance at the base membership tier, or users who would benefit more from structured dietitian-led programs.

The Bottom Line on Cost-Effectiveness

Levels is a well-designed consumer technology product built on a clinical tool whose evidence base does not yet fully support its marketed use case. The annual cost of $349, $2,599 (depending on sensor cadence) places it squarely in the premium wellness category.

For a non-diabetic adult spending $199/year on the membership alone, the question is whether proprietary glucose scores and trend reports change behavior in ways that cheaper interventions (food journaling, a single dietitian consultation, or a $40 home glucose meter for periodic spot-checks) do not. The available evidence, including the JAMA Internal Medicine RCT showing no significant dietary improvement from CGM in healthy adults [6], suggests that for most people, the answer is no. For the subset of users with prediabetes, specific metabolic questions, or the analytical disposition to act on continuous data, a time-limited Levels subscription of 1 to 3 months at $349, $799 total cost represents the most defensible investment.